Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh

Pyrazinamide (PZA) is a frontline antituberculosis (anti-TB) drug used in both first- and second-line treatment regimens. However, due to complex laboratory requirements, the PZA susceptibility test is rarely performed, leading to a scarcity of data on susceptibility to PZA. Bangladesh is a country...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahman, Arfatur, Ferdous, Sara Sabrina, Ahmed, Shahriar, Rahman, S. M. Mazidur, Uddin, Mohammad Khaja Mafij, Pholwat, Suporn, Gratz, Jean, Houpt, Eric, Banu, Sayera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2017
Materias:
Susceptibility
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571327/
https://www.ncbi.nlm.nih.gov/pubmed/28630193
http://dx.doi.org/10.1128/AAC.00511-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571327/
https://www.ncbi.nlm.nih.gov/pubmed/28630193
http://dx.doi.org/10.1128/AAC.00511-17

Ejemplares similares